This page shows you the latest news items in this category. This is page number 16.

Total 219918 results found since Jan 2013.

Study on Bisphosphonates Targeting Triple-negative Breast Cancer
Condition:   Breast Cancer Intervention:   Drug: Zoledronic Acid Sponsors:   Shengjing Hospital;   Liaoning Tumor Hospital & Institute;   The People's Hospital of Liaoning Province Not yet recruiting
Source: ClinicalTrials.gov - August 5, 2019 Category: Research Source Type: clinical trials

Effects of Mediterranean Diet Based Intervention in Breast Cancer Patients
Conditions:   Breast Cancer;   Obesity Intervention:   Behavioral: Mediterranean diet Sponsor:   Gangnam Severance Hospital Not yet recruiting
Source: ClinicalTrials.gov - August 5, 2019 Category: Research Source Type: clinical trials

CollPlant is Developing 3D-bioprinted Implants for Regeneration of Breast Tissue
REHOVOT, Israel, Aug. 5, 2019 -- (Healthcare Sales & Marketing Network) -- CollPlant (NASDAQ: CLGN) (the "Company"), a regenerative medicine company, announced today that it is developing 3D bioprinted implants for regeneration of breast tissue ... Regenerative Medicine CollPlant, 3D bioprinting, recombinant human collagen
Source: HSMN NewsFeed - August 5, 2019 Category: Pharmaceuticals Source Type: news

Finances Affect Women's Choice of Breast Cancer Treatment: Study
Title: Finances Affect Women's Choice of Breast Cancer Treatment: StudyCategory: Health NewsCreated: 8/2/2019 12:00:00 AMLast Editorial Review: 8/5/2019 12:00:00 AM
Source: MedicineNet Cancer General - August 5, 2019 Category: Cancer & Oncology Source Type: news

AI finds distinct breast cancer types that will help target treatment
UK researchers have used artificial intelligence (AI) technology to recognise patterns in breast cancer, leading them to uncover five new types of the disease each matched to different treatments.
Source: Nursing Times - August 5, 2019 Category: Nursing Source Type: news

What Characterizes Breast Cancer in Adolescent and Young Adult Patients?
Researchers looked at the characteristics of breast cancer found in patients under 40 years old.
Source: CancerNetwork - August 5, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Where Does T-DM1 Fit In First-Line Treatment for HER2-Positive Breast Cancer?
A phase III trial tested trastuzumab emtansine (T-DM1) with or without pertuzumab in patients with HER2-positive metastatic breast cancer.
Source: CancerNetwork - August 5, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Impact of genetic counseling on the uptake of contralateral prophylactic mastectomy among younger women with breast cancer.
Conclusion: The risk stratification obtained through genetic counseling had a considerable impact on the surgical decision-making among younger women with breast cancer at long-term follow-up. PMID: 31379231 [PubMed - as supplied by publisher]
Source: Acta Oncologica - August 5, 2019 Category: Cancer & Oncology Authors: Terkelsen T, Rønning H, Skytte AB Tags: Acta Oncol Source Type: research

MiR-16-5p inhibits breast cancer by reducing AKT3 to restrain NF-kB pathway.
CONCLUSION: It can be seen that miR-16-5p exhibits a low expression in breast cancer tissues, which can inhibit breast cancer by restraining the NF-κB pathway and elevating reducing AKT3. PMID: 31383783 [PubMed - as supplied by publisher]
Source: Bioscience Reports - August 5, 2019 Category: Biomedical Science Authors: Ruan L, Qian X Tags: Biosci Rep Source Type: research

Fluorescence ‐based discrimination of breast cancer cells by direct exposure to 5‐aminolevulinic acid
Direct exposure to 5 ‐aminolevulinic acid and Ko143 may be a promising strategy for efficient fluorescence detection of breast cancer cells ex vivo using fine needle aspiration. AbstractProtoporphyrin IX ‐fluorescence measurement is a powerful in situ approach for cancer detection after oral/topical administration of 5‐aminolevulinic acid. However, this approach has not been clinically established for breast cancer, probably due to insufficient delivery of 5‐aminolevulinic acid to the mammary glands. In the present study, we directly exposed breast cancer cells to 5‐aminolevulinic acid to assess their discriminat...
Source: Cancer Medicine - August 5, 2019 Category: Cancer & Oncology Authors: Midori Morita, Hideo Tanaka, Yasuaki Kumamoto, Akihiro Nakamura, Yoshinori Harada, Takehiro Ogata, Koichi Sakaguchi, Tetsuya Taguchi, Tetsuro Takamatsu Tags: ORIGINAL RESEARCH Source Type: research

Characterisation of DNA methylation changes in EBF3 and TBC1D16 associated with tumour progression and metastasis in multiple cancer types.
CONCLUSIONS: These findings suggest characteristic DNA methylation changes in EBF3 and TBC1D16 are relatively common tumour-associated epigenetic events in multiple tumour types, which is consistent with a potential role as more general drivers of tumour progression. PMID: 31383000 [PubMed - in process]
Source: Clinical Breast Cancer - August 5, 2019 Category: Cancer & Oncology Authors: Rodger EJ, Chatterjee A, Stockwell PA, Eccles MR Tags: Clin Epigenetics Source Type: research

Assessment of Transporter Polymorphisms as a Factor in a BCRP Drug Interaction Study With Lanabecestat.
Abstract Lanabecestat is a human β-site amyloid precursor protein-cleaving enzyme 1 inhibitor in development to slow disease progression in patients with early Alzheimer's disease. The study evaluated the breast cancer resistance protein (BCRP) inhibition potential of lanabecestat on the pharmacokinetics (PK) of rosuvastatin, a probe for BCRP activity, in healthy white subjects who were not carriers of SLCO1B1 (c.521T>C), not homozygotes for ABCG2 (c.421C>A or c.34G>A), and not heterozygotes of ABCG2 (c.421C>A and c.34G>A). The safety of lanabecestat + rosuvastatin, the effects of rosuvastatin on t...
Source: Clinical Breast Cancer - August 5, 2019 Category: Cancer & Oncology Authors: Willis BA, Andersen SW, Ayan-Oshodi M, James DE, Liffick E, Hillgren K, Guo Y, Monk SA Tags: J Clin Pharmacol Source Type: research

A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer.
CONCLUSION: Irinotecan and etoposide demonstrated only modest clinical activity and poor tolerability in patients with MBC refractory to anthracycline, taxane, and capecitabine therapy. Further studies testing a lower dose and/or different schedule could be considered given ease of administration and responses seen. PMID: 31383812 [PubMed - as supplied by publisher]
Source: The Oncologist - August 5, 2019 Category: Cancer & Oncology Authors: Segar JM, Reed D, Stopeck A, Livingston RB, Chalasani P Tags: Oncologist Source Type: research

A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma
Modern Pathology, Published online: 05 August 2019; doi:10.1038/s41379-019-0337-2A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma
Source: Modern Pathology - August 5, 2019 Category: Pathology Authors: Kirill A. Lyapichev Sergio Pi ña-Oviedo L. Jeffrey Medeiros Mark G. Evans Hui Liu Alonso R. Miranda Kelly K. Hunt Mark W. Clemens John M. Stewart Mitual B. Amin Andres E. Quesada Siaw Ming Chai Arianna Di Napoli Arthy Yoga Sanat K. Dave Ignacio I. Wistub Source Type: research

Examining Breast Cancer Screening Behavior Among Southern Black Women After the 2009 US Preventive Services Task Force Mammography Guideline Revisions
AbstractUpdated United States Preventive Services Task Force (USPSTF) and American Cancer Society mammography screening recommendations push for increased age of initiation and lengthened breast cancer screening intervals. These changes have implications for the reduction of breast cancer mortality in Black women. The purpose of this study was to examine breast cancer screening behavior in a cohort of Southern Black women after the release of the 2009 USPSTF recommendations. Surveys assessing cancer screening information were collected from members of Black churches between 2006 and 2013. The sample was restricted to women...
Source: Journal of Community Health - August 5, 2019 Category: International Medicine & Public Health Source Type: research

Association Between Vitamin D Levels And Coronary Artery, Aortic Valve And Breast Artery Calcification
Background and Aims: Vitamin D has pleomorphic effects on cardiovascular system and it is well known that vitamin D deficiency is related with atherosclerosis. Vitamin D deficiency is associated with coronary artery calcification . Vitamin D also plays significant role in vascular calcification including breast artery calcification and aortic stenosis. We aimed to evalute the association between vitamin D levels and coronary artery, breast artery and aortic valve calcification.
Source: Atherosclerosis - August 5, 2019 Category: Cardiology Authors: Y.Z. Şener, M. Okşul, A. Yıldırım, S. Sarıkaya, Y. Sarıkaya, V. Hekimsoy, E. Yılmaz, M.G. Akpınar, U. Canpolat, T. Hazırolan, S.L. Tokgözoğlu Tags: Posters 26 - 29 May, 2019 Source Type: research

Effects Of Folic Acid On Progesterone-Enhanced Breast Cancer Cell Proliferation And Migration
Background and Aims: Previously, we have demonstrated that female sex hormone receptors and folic acid receptor form a complex and female sex hormones can abolish the folic acid-inhibited proliferation and migration in endothelial cells. The aim of this study was to investigate whether folic acid can interfere with the progesterone-enhanced breast cancer cell proliferation and migration.
Source: Atherosclerosis - August 5, 2019 Category: Cardiology Authors: H.C. Wang, Y.N. Hui, W.S. Lee Tags: Posters 26 - 29 May, 2019 Source Type: research

Small molecule HDAC inhibitors: Promising agents for breast cancer treatment.
In conclusion, HDACIs have shown desirable effects on breast cancer, especially when they are used in combination with other anticancer agents. In the coming future, more multicenter and randomized Phase III studies are expected to be conducted pushing promising new therapies closer to the market. In addition, the design and synthesis of novel HDACIs are also needed. PMID: 31408831 [PubMed - as supplied by publisher]
Source: Bioorganic Chemistry - August 5, 2019 Category: Chemistry Authors: Huang M, Zhang J, Yan C, Li X, Zhang J, Ling R Tags: Bioorg Chem Source Type: research

Electrochemical aptasensor for the detection of HER2 in human serum to assist in the diagnosis of early stage breast cancer.
Abstract Human epidermal growth factor receptor-2 (HER2) is an important biomarker in the diagnosis and prognosis of breast cancer. This work aimed to develop an aptasensor to detect HER2 in human serum. HER2 aptamer was immobilized by electrostatic adsorption on the surface of a homemade screen-printed electrode modified with poly-L-lysine. Measurements were made by differential pulse voltammetry using methylene blue as a redox indicator. A calibration curve was constructed (R2 = 0.997) using different concentrations of HER2 protein (10-60 ng/mL) in PBS buffer (pH 7.4), with a detection limit of 3.0 ng/mL. The ap...
Source: Analytical and Bioanalytical Chemistry - August 5, 2019 Category: Chemistry Authors: Bezerra G, Córdula C, Campos D, Nascimento G, Oliveira N, Seabra MA, Visani V, Lucas S, Lopes I, Santos J, Xavier F, Borba MA, Martins D, Lima-Filho J Tags: Anal Bioanal Chem Source Type: research

Evolution of older patients diagnosed with early breast cancer in Spain between 1998 and 2001 included in El Alamo III project
ConclusionsOur study suggests that older BC patients have worse outcomes what can be a consequence of receiving inadequate adjuvant treatments. Specific trials for these patients are warranted to allow us to treat them with the same scientific rigor than younger patients.
Source: Clinical and Translational Oncology - August 5, 2019 Category: Cancer & Oncology Source Type: research

Mastectomy and immediate breast reconstruction in the elderly: Trends and outcomes
Immediate breast reconstruction after mastectomy may confer more complication rates in the elderly. Therefore, granular analysis of postmastectomy complications in women aged ≥65 years may help formulate clinical guidelines to improve patient selection and outcomes.
Source: Surgery - August 5, 2019 Category: Surgery Authors: Alaa Sada, Courtney N. Day, Tanya L. Hoskin, Amy C. Degnim, Elizabeth B. Habermann, Tina J. Hieken Source Type: research

Lithium augmentation to monoamine oxidase-inhibitors in treatment-resistant depressive disorders: case report and overview of literature.
Abstract Three patients suffering from a treatment-resistant depression were being treated with a monoamine oxidase (mao-)inhibitor and received lithium augmentation to achieve better recovery. One patient showed significant improvement of depressive symptoms within 24 hours, one patient showed very little respons and one patient did not respond at all. Literature research led to other casereports, where adding lithium to mao-inhibitors had also been effective. The growing amount of arguments of a positive effect of lithium augmentation to mao-inhibitors asks for more research to collect more evidence and a better...
Source: Tijdschrift voor Psychiatrie - August 4, 2019 Category: Psychiatry Authors: Gudde A, van der Meij A, Spijker J Tags: Tijdschr Psychiatr Source Type: research

Anterior Cruciate Ligament Repair in a Professional Soccer Player Using Internal Brace Ligament Augmentation: A Case Report Focusing on Rehabilitation.
CONCLUSION: This rehabilitation programme after ACL repair with IBLA successfully enabled a professional soccer player to return to his pre-injury playing level. PMID: 31373377 [PubMed - as supplied by publisher]
Source: Surgical Technology International - August 4, 2019 Category: Surgery Tags: Surg Technol Int Source Type: research

Clinical and pathological predictors of recurrence in breast cancer patients achieving pathological complete response to neoadjuvant chemotherapy
ConclusionPatients achieving pCR to NAC showed excellent outcomes. Advanced clinical stage, large tumor size, presence of lymph node metastasis, and HER2 positivity before NAC were identified as significant predictors of cancer recurrence. Residual in situ ductal and lymph node diseases after NAC were not significant predictors.
Source: European Journal of Surgical Oncology (EJSO) - August 4, 2019 Category: Surgery Source Type: research

S-equol inhibits proliferation and promotes apoptosis of human breast cancer MCF-7  cells via regulating miR-10a-5p and PI3K/AKT pathway.
We examined the effects of S-equol on proliferation and apoptosis of MCF-7 cells by cell counting kit-8 assay and flow cytometry. Screening for microRNAs and predicting their target genes using the starBase and Targetscan website, respectively. Protein expression was detected by Western blot. The microRNA level were quantified by real-time PCR. The results showed that S-equol inhibited the proliferation of breast cancer MCF-7 cells in a time- and dose-dependent manner and promoted apoptosis of MCF-7 cells. The expression of miR-10a-5p was significantly decreased in breast cancer tissues and breast cancer cell lines, ...
Source: Archives of Biochemistry and Biophysics - August 4, 2019 Category: Biochemistry Authors: Zhang J, Ren L, Yu M, Liu X, Ma W, Huang L, Li X, Ye X Tags: Arch Biochem Biophys Source Type: research

Molecules, Vol. 24, Pages 2834: Methylation of the RELA Gene is Associated with Expression of NF- κB1 in Response to TNF-α in Breast Cancer
This study aims to investigate the role of methylation of genes encoding for the NF-κB family in breast cancer. We analyze the DNA methylation status of the NFKB1 gene and the RELA gene in breast cancer using pyrosequencing. The expression of NF-κB1 and RELA proteins is assessed and the level of RNA transcripts in frozen tissue is determined using RT-PCR. There is no statistically significant difference in the methylation status of the NFKB1 and the RELA genes between tumors and normal tissues. The methylation status of the NFKB1 gene and the RELA gene is not significantly associated with the le...
Source: Molecules - August 4, 2019 Category: Chemistry Authors: Young Ju Jeong Hoon Kyu Oh Hye Ryeon Choi Tags: Article Source Type: research

Molecular Analysis of V617F Mutation in Janus Kinase 2 Gene of Breast Cancer Patients
ConclusionsEnvironmental and clinical risk factors were associated with breast cancer which can be overcome by improving awareness of associated risks, health facilities and reducing stress.
Source: Saudi Journal of Biological Sciences - August 3, 2019 Category: Biology Source Type: research

Redox modifications of cysteine-containing proteins, cell cycle arrest and translation inhibition: Involvement in vitamin C-induced breast cancer cell death
This study provides insight into the redox-based mechanisms of VitC anticancer activity, indicating that pharmacologic doses of VitC and VitC-based rational drug combinations could be novel therapeutic opportunities for triple-negative breast cancer.Graphical abstract
Source: Redox Biology - August 3, 2019 Category: Biology Source Type: research

Luteolin exhibits anti-breast cancer property through up-regulating miR-203.
This study designed to check its impact on breast cancer and the underlying mechanisms. MDA-MB-453 and MCF-7 cells were administrated with luteolin and the following techniques were carried out: CCK-8 assay, FITC-PI double-staining and Western blot. qRT-PCR analysis was utilized to see the effects of luteolin on miR-203 expression. Besides, miR-203 expression was silenced by transfection with specific inhibitor. Luteolin remarkably declined MDA-MB-453 and MCF-7 cells viability and accelerated apoptosis which accompanied by Bax up-regulation, Bcl-2 down-regulation and Caspase-3 cleavage. Also, luteolin impeded TGFβ1-induce...
Source: Artificial Cells, Nanomedicine and Biotechnology - August 3, 2019 Category: Biotechnology Tags: Artif Cells Nanomed Biotechnol Source Type: research

Mediators of physical activity adoption and maintenance among breast cancer survivors
AbstractThe purpose of this study is to explore the mediators associated with physical activity (PA) within the adoption and maintenance phase of a PA intervention trial among breast cancer survivors. Overall, 192 breast cancer survivors (average age  = 55.9 years) were randomized to an Intervention or Control group. Both groups received 8 calls in the first 3-months, 3 monthly calls, and then entered a no-contact maintenance phase for the remaining 6-months. Assessments were completed at baseline, 3-months, 6-months and 12-months. On avera ge, participants were 55.9 years of age (SD = 9.8) and 2.9 years since d...
Source: Journal of Behavioral Medicine - August 3, 2019 Category: Psychiatry Source Type: research

Incidence of interstitial pneumonitis in breast cancer patients treated with pegylated liposomal doxorubicin
ConclusionClinicians should pay attention to CIIP in breast cancer patients who receive more than three cycles of chemotherapy regimens containing pegylated liposomal doxorubicin plus cyclophosphamide with or without docetaxel.
Source: Cancer Chemotherapy and Pharmacology - August 3, 2019 Category: Cancer & Oncology Source Type: research

Arthroscopic subscapularis augmentation combined with capsulolabral reconstruction is safe and reliable
ConclusionFor RASI with GBL  <  25%, MASA with tenodesis of the upper third of the subscapularis tendon using a tendon combined with capsulolabral reconstruction was a safe technique that produced better outcomes in terms of ASES scores, VAS scores, OSISs, the return to sports, and postoperative recurrent instability and did no t decrease the ROM compared to that achieved by arthroscopic Bankart repair.Level of evidenceIII.
Source: Knee Surgery, Sports Traumatology, Arthroscopy - August 3, 2019 Category: Orthopaedics Source Type: research

Determinants of persistent organic pollutant (POP) concentrations in human breast milk of a cross-sectional sample of primiparous mothers in Belgium.
CONCLUSIONS: Dietary and non-dietary determinants predict individual POP concentrations in breast milk. PMID: 31387080 [PubMed - as supplied by publisher]
Source: Environment International - August 3, 2019 Category: Environmental Health Authors: Aerts R, Van Overmeire I, Colles A, Andjelković M, Malarvannan G, Poma G, Den Hond E, Van de Mieroop E, Dewolf MC, Charlet F, Van Nieuwenhuyse A, Van Loco J, Covaci A Tags: Environ Int Source Type: research

The Impact of Education on Knowledge Attitude and Practice of Breast Self-Examination Among Adolescents Girls at the Fiwasaye Girls Grammar School Akure, Nigeria
AbstractBreast cancer is the second most common cancer in women aged 15 –45 after the non-melanoma of the skin. Lack of knowledge and practice of breast self-examination (BSE) have been blamed for the high morbidity and mortality associated with breast cancer among women and adolescents in particular. The study assessed the impact of education on knowledge, attitude a nd practice of breast self-examination among adolescent girls. A quasi-experimental study of only one group was conducted among school-going adolescents at Fiwasaye Girls Grammar School in Akure, Ondo State, Nigeria. Data were collected using a self-develop...
Source: Journal of Cancer Education - August 3, 2019 Category: Cancer & Oncology Source Type: research

Assessing the impact of the 2018 American Society of Clinical Oncology/College of American Pathologists recommendations on human epidermal growth factor receptor 2 testing by fluorescence in situ hybridization in breast carcinoma
AbstractThe American Society of Clinical Oncology/College of American Pathologists recently updated their recommendations on human epidermal growth factor receptor 2 (HER2) testing by fluorescence in situ hybridization (FISH) in invasive breast cancer, with a focus on the clarification of less common test patterns of ISH. We assessed the impact of the updated ASCO/CAP guidelines on 1044 FISH tested tumors by comparing categorization according to the 2007, 2013, and 2018 ISH classification criteria. The 2013 guidelines increased the number of positive cases (17.4% vs 10.7%) identifying 70 (6.7%) additional patients who met ...
Source: Virchows Archiv - August 3, 2019 Category: Pathology Source Type: research

Silencing lncRNA SNHG6 suppresses proliferation and invasion of breast cancer cells through miR-26a/VASP axis
Publication date: Available online 1 August 2019Source: Pathology - Research and PracticeAuthor(s): Kai Li, Yan-bin Ma, Yi-hao Tian, Xiao-long Xu, Yang Gao, Yan-qi He, Wen-ting Pan, Jing-wei Zhang, Chun-jiang He, Lei WeiAbstractThe important role of LncRNA in the development of breast cancer is attracting more and more attention. In the previous study, we found that the expression level of LncRNA SNHG6 in breast cancer tissues and cells was significantly increased, but its mechanism in the development of breast cancer was still unclear. Our study found that knockdown of SNHG6 significantly inhibited the proliferation, migr...
Source: Pathology Research and Practice - August 2, 2019 Category: Pathology Source Type: research

Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer
Publication date: Available online 1 August 2019Source: Seminars in Cancer BiologyAuthor(s): Billy Samuel Hill, Annachiara Sarnella, Giuliana D’Avino, Antonella ZannettiAbstractCurrently, metastasis remains the primary cause of death of patients with breast cancer despite the important advances in the treatment of this disease. In the complex tumour microenvironment network, several malignant and non-malignant cell types as well as components of extracellular matrix cooperate in promoting the metastatic spread of breast carcinoma. Many components of the stromal compartment are recruited from distant sites to the tumour i...
Source: Seminars in Cancer Biology - August 2, 2019 Category: Cancer & Oncology Source Type: research

Finances Affect Women ' s Choice of Breast Cancer Treatment: Study
FRIDAY, Aug. 2, 2019 -- Cost often influences breast cancer patients ' decisions about surgery, even if they have good incomes and insurance, a new study finds. " Eligible women with early-stage breast cancer often have choices for surgical...
Source: Drugs.com - Daily MedNews - August 2, 2019 Category: General Medicine Source Type: news

Effect of Sukshma Vyayama Yoga on Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors
Condition:   Breast Cancer Intervention:   Behavioral: Joint Loosening Yoga Sponsors:   AshtaYoga, LLC;   Columbia University;   Swami Vivekananda Yoga Anusandhana Samsthana Completed
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials

DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer
Conditions:   HER2 Breast Cancer;   Non-small Cell Lung Carcinoma Interventions:   Drug: Trastuzumab deruxtecan (DS-8201a);   Drug: Pembrolizumab Sponsors:   Daiichi Sankyo, Inc.;   AstraZeneca UK Limited;   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials

Effect of Sukshma Vyayama Yoga on Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors
Condition:   Breast Cancer Intervention:   Behavioral: Joint Loosening Yoga Sponsors:   AshtaYoga, LLC;   Columbia University;   Swami Vivekananda Yoga Anusandhana Samsthana Completed
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials

DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer
Conditions:   HER2 Breast Cancer;   Non-small Cell Lung Carcinoma Interventions:   Drug: Trastuzumab deruxtecan (DS-8201a);   Drug: Pembrolizumab Sponsors:   Daiichi Sankyo, Inc.;   AstraZeneca UK Limited;   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials

Effect of Sukshma Vyayama Yoga on Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors
Condition:   Breast Cancer Intervention:   Behavioral: Joint Loosening Yoga Sponsors:   AshtaYoga, LLC;   Columbia University;   Swami Vivekananda Yoga Anusandhana Samsthana Completed
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials

DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer
Conditions:   Breast Cancer;   Non-small Cell Lung Carcinoma Interventions:   Drug: Trastuzumab deruxtecan (DS-8201a);   Drug: Pembrolizumab Sponsors:   Daiichi Sankyo, Inc.;   AstraZeneca UK Limited;   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials

Effect of Sukshma Vyayama Yoga on Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors
Condition:   Breast Cancer Intervention:   Behavioral: Joint Loosening Yoga Sponsors:   AshtaYoga, LLC;   Columbia University;   Swami Vivekananda Yoga Anusandhana Samsthana Completed
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials

DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer
Conditions:   HER2 Breast Cancer;   Non-small Cell Lung Carcinoma Interventions:   Drug: Trastuzumab deruxtecan (DS-8201a);   Drug: Pembrolizumab Sponsors:   Daiichi Sankyo, Inc.;   AstraZeneca UK Limited;   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials